Item 3.02 Unregistered Sales of
The disclosure provided in Part B of Item 5.02 of this Report is hereby incorporated by reference into this Item 3.02.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
A. On
B. On
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company held its Annual Meeting on
Proposal 1: To elect four directors of the Company, three of whom shall be independent directors as defined by applicable rules, to serve for a one-year term expiring in 2021.
Name of Director For Withheld Broker Non-Vote Oleg Firer 1,393,772 54,556 2,069,269 John Roland 1,333,772 40,556 2,069,269 Jon Najarian 1,155,387 218,941 2,069,269 Todd Raarup 1,333,727 40,601 2,069,269
All director nominees were duly elected.
2 --------------------------------------------------------------------------------
Proposal 2: To approve an amendment to the Company's 2013 Equity Incentive Plan, as amended (the "Plan"), to increase the number of shares of Common Stock authorized for issuance under the Plan by 210,500 shares of Common Stock resulting (if such increase is authorized by the shareholders) in the aggregate 1,160,500 shares authorized for issuance under the Plan, which represents in the aggregate approximately 23.95% of our issued and outstanding Common Stock.
For Against Abstain Broker Non-Vote 1,032,247 329,638 12,443 2,069,269 Proposal 2 was approved.
Proposal 3: To approve the issuance by the Company of 119,361 restricted shares
of Common Stock to the Company's Chief Executive Officer,
For Against Abstain Broker Non-Vote 1,008,075 357,469 8,784 2,069,269 Proposal 3 was approved.
Proposal 4: To approve the issuance by the Company of 12,287 restricted shares
of Common Stock to the Company's Chief Legal Officer,
For Against Abstain Broker Non-Vote 1,004,996 359,442 9,890 2,069,269 Proposal 4 was approved.
Proposal 5: To approve the issuance by the Company of 4,824 restricted shares of
Common Stock to the Company's Chief Financial Officer,
For Against Abstain Broker Non-Vote 1,007,012 353,509 13,807 2,069,269 Proposal 5 was approved.
Proposal 6: To approve the issuance by the Company of 3,909 restricted shares of
Common Stock to the Company's Chief Technology Officer,
For Against Abstain Broker Non-Vote 1,002,833 357,974 13,521 2,069,269 Proposal 6 was approved.
Proposal 7: To approve the issuance by the Company of 13,107 restricted shares
of Common Stock to President of Unified Payments, the Company's subsidiary,
For Against Abstain Broker Non-Vote 1,004,306 359,079 10,943 2,069,269 Proposal 7 was approved. 3 --------------------------------------------------------------------------------
Proposal 8: To approve the issuance by the Company of 8,730 restricted shares of
Common Stock to the Company's in-house counsel in
For Against Abstain Broker Non-Vote 1,010,163 353,362 10,803 2,069,269 Proposal 8 was approved.
Proposal 9: To ratify the selection of
For Against Abstain 2,964,698 462,016 16,883 Proposal 9 was approved.
Proposal 10: To approve, on an advisory (nonbinding) basis, the compensation of the Company's named executive officers.
For Against Abstain Broker Non-Vote 1,035,034 329,308 9,986 2,069,269 Proposal 10 was approved.
Proposal 11: To approve, on an advisory (nonbinding) basis, the frequency of advisory votes on the compensation of the Company's named executive officers.
Three Years Two Years One Year Abstain Broker Non-Vote 926,303 52,153 355,585 40,287 2,069,269
Proposal 11 was approved with three years as the frequency of advisory votes on the compensation of the Company's named executive officers.
4
--------------------------------------------------------------------------------
© Edgar Online, source